Viatris Inc.

General ticker "VTRS" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $13.3B (TTM average)

Viatris Inc. follows the US Stock Market performance with the rate: 39.2%.

Estimated limits based on current volatility of 1.4%: low 8.49$, high 8.73$

Factors to consider:

  • Earnings expected soon, date: 2025-05-08 bmo
  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2025-03-10, amount 0.12$ (Y5.66%)
  • China accounted for 13.3% of revenue in the fiscal year ended 2024-12-31
  • US accounted for 23.9% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [8.41$, 14.44$]
  • 2025-12-31 to 2026-12-31 estimated range: [6.89$, 12.40$]

Financial Metrics affecting the VTRS estimates:

  • Negative: negative Net income
  • Positive: Non-GAAP EPS, $ of 2.65 > 2.19
  • Positive: Operating cash flow per share per price, % of 15.17 > 12.73
  • Positive: -0.07 < Operating profit margin, % of 0.07
  • Positive: Interest expense per share, $ of 0.46 <= 0.67
  • Positive: 43.26 < Shareholder equity ratio, % of 44.90 <= 63.75
  • Negative: negative Industry operating income (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -8.00 <= 2.82

Similar symbols

Short-term VTRS quotes

2025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-0677.588.59
Price $

Long-term VTRS plot with estimates

7891011121314Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.20.40.60.8
VTRSS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $16,258.30MM $15,315.30MM $14,388.40MM
Operating Expenses $14,643.40MM $14,549.10MM $14,378.30MM
Operating Income $1,614.90MM $766.20MM $10.10MM
Non-Operating Income $1,198.30MM $-563.30MM $-633.30MM
Interest Expense $592.40MM $573.10MM $550.00MM
R&D Expense $698.60MM $910.70MM $837.00MM
Income(Loss) $2,813.20MM $202.90MM $-623.20MM
Taxes $734.60MM $148.20MM $11.00MM
Profit(Loss)* $2,078.60MM $54.70MM $-634.20MM
Stockholders Equity $21,072.30MM $20,467.40MM $18,635.50MM
Inventory $3,519.50MM $3,469.70MM $3,854.10MM
Assets $50,022.20MM $47,685.50MM $41,500.90MM
Operating Cash Flow $2,999.00MM $2,900.00MM $2,302.90MM
Capital expenditure $443.00MM $474.50MM $326.00MM
Investing Cash Flow $1,474.10MM $-864.50MM $1,800.70MM
Financing Cash Flow $-3,877.90MM $-2,301.90MM $-4,330.40MM
Earnings Per Share** $1.71 $0.05 $-0.53

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.